Grant: Engage Grants Program
Simon Fraser University
$24,300.00
Enhancing quality assurance of medicinal marihuana through DNA fingerprinting
FY 2014-15
Summary
Marihuana (Cannabis sativa L.) is increasingly being recognized for its properties in treating a number ofhuman diseases, such as multiple sclerosis, chronic pain, seizures and PTSD. Cannabis produces a uniquegroup of natural products consisting of over 100 pharmacologically-active compounds (cannabinoids), ofwhich ?9 -Tetrahydrocannabinol (THC) is the principal psychoactive molecule. As well, non-psychoactivecannabinoids, such as cannabidiol (CBD), with a range of pharmacological activities, are also present. Theratios of THC:CBD can determine the therapeutic activities observed.Marihuana plants may be initiated from seeds or more commonly are propagated from vegetative cuttings madefrom stock plants (mother plants). Seeds are used when a new genetic line (strain) is being considered, but issubject to variation in phenotypic characteristics in the offspring due to heterozygosity. Since there are nohighly bred cultivars in marihuana as found in most food crops, eg. tomato, corn, cucumber, genetic lines(strains) exist that are identified by the unique names assigned to them eg. ""Charlotte's Web"", and they vary inTHC:BD ratios. Since there is no accurate pedigree records for most genetic stocks, the extent of geneticvariation among and between these lines is unknown. It is not uncommon for a potential mix-up of geneticlines to occur during commercial production, or for seeds or vegetative propagation to give rise to unusualphenotypes. This creates a problem for quality assurance as well as for monitoring a particular line for geneticstability over time. The availability of a DNA fingerprinting method that can be used to distinguish amongselected lines, as well as to study the extent of genetic variation among a wide range of lines and seed sources,would be invaluable as a rapid screen for quality assurance and genetic fidelity, in addition to providingscientifically interesting data on this plant. Any method developed could potentially be put into routinecommercial use in a very short time-frame and would be a first step to assure genetic identity in therapidly-growing area of marihuana cultivation in Canada.
Program
Engage Grants Program
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
476662-2014
Name nom
Punja, Zamir
Department département
Biological Sciences
Organization id
5
Institution établissement
Simon Fraser University
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2014
Award amount
24300
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1554
Committee name en
Pacific Internal Decision Committee
Committee name fr
Comité de décision interne pour le Pacifique
Area of application code
103
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Plant production and plant primary products
Area of application fr
Production végétale et produits végétaux primaires
Research subject code
4900
Research subject group en
Plant and treebiology
Research subject group fr
Biologie végétale et des arbres
Research subject en
Plant and treebiology
Research subject fr
Biologie végétale et des arbres
Partie
1
Nb partie
1
Application title
Enhancing quality assurance of medicinal marihuana through DNA fingerprinting
Keyword
NSERC
Application summary
Marihuana (Cannabis sativa L.) is increasingly being recognized for its properties in treating a number ofhuman diseases, such as multiple sclerosis, chronic pain, seizures and PTSD. Cannabis produces a uniquegroup of natural products consisting of over 100 pharmacologically-active compounds (cannabinoids), ofwhich ?9 -Tetrahydrocannabinol (THC) is the principal psychoactive molecule. As well, non-psychoactivecannabinoids, such as cannabidiol (CBD), with a range of pharmacological activities, are also present. Theratios of THC:CBD can determine the therapeutic activities observed.Marihuana plants may be initiated from seeds or more commonly are propagated from vegetative cuttings madefrom stock plants (mother plants). Seeds are used when a new genetic line (strain) is being considered, but issubject to variation in phenotypic characteristics in the offspring due to heterozygosity. Since there are nohighly bred cultivars in marihuana as found in most food crops, eg. tomato, corn, cucumber, genetic lines(strains) exist that are identified by the unique names assigned to them eg. ""Charlotte's Web"", and they vary inTHC:BD ratios. Since there is no accurate pedigree records for most genetic stocks, the extent of geneticvariation among and between these lines is unknown. It is not uncommon for a potential mix-up of geneticlines to occur during commercial production, or for seeds or vegetative propagation to give rise to unusualphenotypes. This creates a problem for quality assurance as well as for monitoring a particular line for geneticstability over time. The availability of a DNA fingerprinting method that can be used to distinguish amongselected lines, as well as to study the extent of genetic variation among a wide range of lines and seed sources,would be invaluable as a rapid screen for quality assurance and genetic fidelity, in addition to providingscientifically interesting data on this plant. Any method developed could potentially be put into routinecommercial use in a very short time-frame and would be a first step to assure genetic identity in therapidly-growing area of marihuana cultivation in Canada.